• 不 限
  • 期刊论文
  • 硕博论文
  • 会议论文
  • 报 纸
  • 英文论文
  2. 您的位置
  3. 首页
  4. 会议论文
  5. Association of Platelet Activation with Liver Injury Triggered by Hematopoietic Stem Cell Transplant

Association of Platelet Activation with Liver Injury Triggered by Hematopoietic Stem Cell Transplant

来源 :第十五届全国实验血液学学术会议 | 被引量 : 0次 | 上传用户：zy205806
【摘 要】
：
Aims To evaluate the relationship between platelet activation and liver damage in patients receiving hematopoietic stem cell transplantation (HSCT).Methods P-selectin expression was measured by flow c
【作 者】
：
齐昆明 安立才 潘彬 陈伟 吴庆运 曹江 李振宇 曾令宇 徐开林 
【机 构】
：
徐州医学院附属医院
【出 处】
：
第十五届全国实验血液学学术会议
【发表日期】
：
2015年3期
【关键词】
：
Platelet Activation Liver Injury Hematopoietic Stem Cell Transplantation 
下载到本地 , 更方便阅读
下载此文 赞助VIP
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
　　Aims To evaluate the relationship between platelet activation and liver damage in patients receiving hematopoietic stem cell transplantation (HSCT).Methods P-selectin expression was measured by flow cytometry, liver function (level of alanine transaminase (ALT), totalbilirubin (TBIL)) was evaluated by Bio-Chemical Analyzerand pathology changes of liver sinusoid endothelial cell (LSEC) was assessed byH&E, immunohistochemical and Mason staining.
其他文献
High-dose cytarabine for consolidation therapy of acute myeloid leukemia in first complete remission
Background New evidence has questioned the role of high-dose cytarabine (HDAC) in consolidation therapy of acute myeloid leukemia (AML) in first complete remission (CR1).We performed a meta-analysis t
会议
High-dose cytarabineconsolidation therapyacute myeloid leukemia
Co-transplantation with mesenchymal stem cells expressing a SDF-1/HOXB4 fusion protein markedly impr
Introduction Mesenchymal stem cells (MSCs) contribute to the engraftment of transplanted hematopoietic stem cells (HSCs).MSCs also accelerate hematological recovery by secreting SDF-1 and enabling HSC
会议
SDF-1/HOXB4hematopoietic stem cellirradiated mice
The effects of allogeneic stem cell transplantation with matched sibling donor versus autologous ste
Background Multiple myeloma (MM) is a malignant proliferative disease which is characterized by excessive proliferation of abnormal plasma cell originated from post-germinal-center B cells.The choice
会议
The effects of allogeneic stem cell transplantation with matched sibling donor v
Decreased level of cytotoxic T lymphocyte antigen-4 (CTLA-4) in patients with acute immune thrombocy
Objective Previously, we demonstrated the importance ofT-cell immune response cDNA 7 (TIRC7) in acute i mmune thrombocytopenia (ITP).As the downstream molecule of TIRC7, cytotoxic T lymphocyte antigen
会议
acute immune thrombocytopenia(ITP)cytotoxic T lymphocyte antigen-4(CTLA-4)immu
Comparison of Total Body Irradiation with Busulfan/Cyclophosphamide on the Development of Hepatic Ve
Aims To evaluate and compare the effect of total body irradiation (TBI) with busulfan/cyclophosphamide (BU/CY) as conditioning regimen on the development of hepatic veno-occlusive disease (HVOD) occur
会议
Hematopoietic Stem Cell TransplantationHepatic Veno-Occlusive Disease
Dexamethasone down-regulates Th1 cells by modulating T-cell immune response cDNA7 in acute immune th
Objective T-cell immune response cDNA 7(TIRC7) has been identified and demonstrated to be essential in T cell activation.However, the role of TIRC7 in acute immune thrombocytopenia (ITP) re mains poor
会议
Dexamethasoneacute immune thrombocytopeniaTh1 cellsT-cell immune response cDN
Retuximab successfully treat unicentric Castleman disease complicated by paraneoplastic pemphigus an
Introduction Castleman disease(CD) was named after Dr Benjamin Castleman when he described 13 cases ofmediastinal lymphnode swelling in the year 1956 and is characterized by non-clonal B cell prolifer
会议
RituximabCastleman diseaseparaneoplastic pemphigusbronchitis obsterans
重型血友病A伴高滴度抑制物的免疫耐受诱导治疗一例并文献复习
在血友病A替代治疗过程中FⅧ抑制物的生成是最严重的并发症.免疫耐受诱导治疗(Immune tolerance induction,ITI)可有效清除抑制物.本文报道l例高滴度抑制物血友病A患者,低剂量ITI方案治疗6个月后FⅧ抑制物从高滴度下降为低滴度(范围0.45-3.1BU/ml),输注FⅧ后回收率＞66％,记忆反应消失.随访47个月患者FⅧ抑制物仍为低滴度,加大FⅧ剂量治疗出血事件有效,是国
会议
血友病A抑制物免疫耐受
肿瘤相关巨噬细胞及NK细胞在弥漫大B细胞淋巴瘤组织中的表达及其预后意义
目的 肿瘤相关巨噬细胞及NK细胞在肿瘤微环境中起着重要的作用。本研究拟探讨肿瘤相关巨噬细胞(包括M1型和M2型)以及NK细胞在弥漫大B细胞淋巴瘤中的表达及预后意义。方法 收集南方医科大学医学南方医院2004年6月～2012年10月接受RCHOP4疗程以上正规化疗的弥漫大B淋巴瘤的病例77例。分别以CD68、CD163作为M1和M2型巨噬细胞标记，以CD57作为NK细胞标记，免疫组化二步法检测了DL
会议
弥漫大B细胞淋巴瘤肿瘤相关巨噬细胞NK细胞
改良CVD-T方案治疗老年多发性骨髓瘤的疗效分析
目的 研究改良CVD-T方案治疗老年多发性骨髓瘤患者的临床疗效及安全性.方法 47例初治或复发难治多发性老年骨髓瘤患者,21例接受改良CVD-T方案治疗,26例接受VAD-T方案治疗.按照IMWG标准评价临床治疗疗效,WHO标准判断不良反应发生情况.结果 ①47例患者中位年龄67 (55～76)岁,每例至少完成2个周期改良CVD-T或VAD-T方案的治疗,改良CVD-T组总有效率为52.4％ (1
会议
改良CVD-T方案老年多发性骨髓瘤